<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.peertechzpublications.org/assets/xsl/oaitohtml.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
										<responseDate>2026-06-03T08:18:43Z</responseDate>
										<request verb="GetRecord" metadataPrefix="oai_dc" identifier="oai:www.peertechzpublications.org:10.17352/jgro.000068">https://www.peertechzpublications.org/oai-pmh</request><GetRecord><record>
								<header>
									<identifier>oai:www.peertechzpublications.org:10.17352/jgro.000068</identifier>
									<datestamp>2019-08-02</datestamp>
									<setSpec>PTZ.JGRO:VOL5</setSpec>
								</header>
								<metadata>
									<oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
										<dc:title>
										Evaluation of effi cacy &amp; safety of oral fi xed dose combination of probiotics in bacterial vaginosis
										</dc:title><dc:creator>Arif Ahmed Faruqui</dc:creator><dc:description>&lt;p&gt;&lt;strong&gt;Aim&lt;/strong&gt;: To evaluate the effi cacy and safety of vaginal specifi c lactobacilli strain in management of bacterial vaginosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Method&lt;/strong&gt;: A non-randomized, open labeled, non-comparative, multi-centric, study was conducted in total of 58 female patients suffering from bacterial vaginosis. Each patient was administered a combination of four strains of Lactobacilli. Vaginal pH, discharge, odor, itching and painful urination were performed at baseline, week 2 and week 4 as assessment parameters.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Result&lt;/strong&gt;: At the end of study data was extractable in only 56 females (mean age was 34.57 ± 11 years). Associated BV symptoms like vaginal discharge, odor and painful urination reduced signifi cantly at week 4 as compared to baseline. The most frequently encountered symptom was vaginal discharge, vaginal pH, odor and itching. With a shift in pH&amp;lt;4.5, at the end of week 4 all females showed improvement in the vaginal microbiota. Tolerability of fi xed dose combination was found to be good and none of the subjects discontinued the treatment.&lt;/p&gt;</dc:description>
										<dc:publisher>Journal of Gynecological Research and Obstetrics - Peertechz Publications</dc:publisher>
										<dc:date>2019-08-02</dc:date>
										<dc:type>Research Article</dc:type>
										<dc:identifier>https://doi.org/10.17352/jgro.000068</dc:identifier>
										<dc:language>en</dc:language>
										<dc:rights>Copyright © Arif Ahmed Faruqui et al.</dc:rights>
									</oai_dc:dc>
								</metadata>
							</record></GetRecord>
						</OAI-PMH>
